Rating History for Bristol-Myers Squibb Co. (BMY) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/5/2026 | David Risinger | Downgrade | Market Perform (Outperform) |
59.00 (N/A) |
61.15 (60.55) |
-0.98% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
